Kroger Clarify Care Acne Wash

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with the letter "A" on one side and the number "1" on the opposite side. Each tablet contains 1 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and color additives.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be covered with a thin layer of the medication and rinsed thoroughly. Initial application should be limited to once daily to minimize the risk of excessive skin drying. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day. Careful monitoring of the skin's response is advised to ensure optimal treatment outcomes while minimizing adverse effects.

Contraindications

Use is contraindicated in patients with a history of eye contact, as exposure may lead to irritation. In the event of contact with the eyes, it is essential to flush thoroughly with water to mitigate potential adverse effects.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent any adverse effects associated with inappropriate use.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients or caregivers are advised to contact a Poison Control Center without delay to ensure appropriate management and intervention.

There are no specific laboratory tests recommended for monitoring the use of this product. However, healthcare providers should remain vigilant and assess the patient's overall health status as necessary.

In summary, the emphasis on external use and the protocol for managing accidental ingestion are critical components of patient safety and should be communicated clearly to all individuals involved in the care and administration of this product.

Side Effects

For external use only. No specific adverse reactions have been reported in clinical trials or postmarketing experiences. Patients should be advised to adhere strictly to the recommended usage guidelines to minimize the risk of adverse effects.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Kroger Clarify Care Acne Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

Due to the lack of available data, it is advisable to closely monitor elderly patients for any potential adverse effects or changes in therapeutic response. Individualized assessment and consideration of the patient's overall health status, comorbidities, and concurrent medications are recommended to ensure safe and effective use in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Therefore, pregnant women should avoid using products containing salicylic acid to mitigate any potential risks to fetal outcomes. Healthcare professionals are advised to counsel women of childbearing potential regarding these risks and to recommend alternative treatments that are deemed safer during pregnancy.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed that skin irritation and dryness may be more likely to occur if they use another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. If contact does occur, patients should be instructed to flush the eyes thoroughly with water to mitigate any potential irritation.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is important to note that the product may stain some fabrics, and care should be taken to avoid contact with such materials.

For optimal storage, the product should be kept at controlled room temperature, ensuring that it is protected from excessive heat and moisture. Containers should be sealed properly to maintain product integrity and prevent contamination. Special handling precautions should be observed to minimize the risk of staining and to ensure safe usage.

Additional Clinical Information

The medication is administered topically, covering the entire affected area with a thin layer, and should be rinsed thoroughly one to three times daily. Patients are advised to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. If bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

Clinicians should counsel patients on the potential for skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is recommended to use only one topical acne medication at a time to minimize irritation. Patients should avoid contact with the eyes, and in the event of contact, they should flush thoroughly with water. Additionally, the medication should be kept out of reach of children, and if swallowed, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Kroger Clarify Care Acne Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)